Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginsana for hemoglobin re-oxygenation in recreational athletes
NCT02182934Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 1999
- Primary completion
- Apr 2000
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Baseline-adjusted half-time hemoglobin re-oxygenation at Day 63. Started Nov 1999; status: completed.
Beyond the preview
Go deeper on NCT02182934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182934.